Otsuka Launches New Company to Commercialize Rejoyn, the First Digital Therapeutic for Depression – MedCity News
Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The app, which changes users’ behavior through various lessons and exercises, was developed by Otsuka…
Continue Reading